Kymera Therapeutics (KYMR) - News Mentions

Sign up to add (KYMR) to your portfolio and access more historical data.

10%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 0%
Gilead Sciences
Gilead Sciences
GILD		 0 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 1 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 1 0%
Franklin Resources Inc. Grows Stock Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR)
December 28
Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal
December 27
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Shares Sold by Geode Capital Management LLC
December 24
HighTower Advisors LLC Invests $494,000 in Kymera Therapeutics, Inc. (NASDAQ:KYMR)
December 21
XTX Topco Ltd Decreases Stock Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR)
December 18
State Street Corp Trims Stock Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR)
December 17
Kymera Therapeutics (NASDAQ:KYMR) versus Kyverna Therapeutics (NASDAQ:KYTX) Critical Analysis
December 11
Head-To-Head Comparison: Editas Medicine (NASDAQ:EDIT) versus Kymera Therapeutics (NASDAQ:KYMR)
December 9
Walleye Capital LLC Takes Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR)
December 9
Kymera Therapeutics (NASDAQ:KYMR) Coverage Initiated by Analysts at BMO Capital Markets
December 8
Brokerages Set Kymera Therapeutics, Inc. (NASDAQ:KYMR) PT at $53.40
December 6
Kymera Therapeutics (NASDAQ:KYMR) Raised to “Overweight” at Wells Fargo & Company
December 4
Fmr LLC Buys 282,301 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR)
December 2
Algert Global LLC Sells 2,450 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR)
November 29
Kymera Therapeutics to Participate in Upcoming December Investor Conferences
November 25
Morgan Stanley Raises Kymera Therapeutics (NASDAQ:KYMR) Price Target to $49.00
November 8

Month over Month

Est. daily news mentions.

Nov 2024 0
Oct 2024 0
Sep 2024 0

How often is Kymera Therapeutics mentioned in the news?

Kymera Therapeutics was mentioned an estimated 1 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Kymera Therapeutics performing compared to its industry peers?

Kymera Therapeutics underperforms its industry peers when it comes to News Mentions, ranking in the 33rd percentile.

Has there been an increase or decrease in news mentions of Kymera Therapeutics in the last month?

There has been no significant change in the number of news mentions for Kymera Therapeutics' compared to the last month.

Why is it important to track news mentions for Kymera Therapeutics?

By monitoring mentions in the news for Kymera Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Kymera Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on Kymera Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact